Antifungal Susceptibility Testing of Fusarium: A Practical Approach
AbstractIn vitro susceptibility testing of Fusarium is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility (EUCAST), but breakpoints (BPs) have not yet been established. One of the problems is that phylogenetic distances between Fusarium species are much smaller than between species of, e.g., Candida. Epidemiological cutoff values (ECVs) for some Fusarium species have been determined in order to differentiate wild-type from non-wild-type isolates. In clinical routine, commercially available assays such as Etest, Sensititre or others provide essential agreement with reference methods. Our objective is to summarize antifungal susceptibility testing of Fusarium genus in the clinical laboratory: how to do it, when to do it, and how to interpret it. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Al-Hatmi, A.M.S.; Curfs-Breuker, I.; de Hoog, G.S.; Meis, J.F.; Verweij, P.E. Antifungal Susceptibility Testing of Fusarium: A Practical Approach. J. Fungi 2017, 3, 19.
Al-Hatmi AMS, Curfs-Breuker I, de Hoog GS, Meis JF, Verweij PE. Antifungal Susceptibility Testing of Fusarium: A Practical Approach. Journal of Fungi. 2017; 3(2):19.Chicago/Turabian Style
Al-Hatmi, Abdullah M.S.; Curfs-Breuker, Ilse; de Hoog, G. S.; Meis, Jacques F.; Verweij, Paul E. 2017. "Antifungal Susceptibility Testing of Fusarium: A Practical Approach." J. Fungi 3, no. 2: 19.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.